This educational webinar was sponsored and directed by Bristol Myers Squibb.
This webinar explores treatment decisions for patients with metastatic renal cell carcinoma. The expert faculty will discuss the main challenges in the treatment of patients with unfavourable prognosis, and specific conditions with the support of clinical cases.
Biographies:
Guillermo de Velasco
Guillermo de Velasco is a renowned medical oncologist with a distinguished focus on genitourinary tumours, melanoma, and early-stage studies. He earned his medical degree from Complutense University in Madrid, Spain, and successfully completed his Medical Oncology residency at the 12 de Octubre Hospital, Madrid, Spain. de Velasco’s achievements include securing prestigious grants from the European Society of Medical Oncology (ESMO) and the Spanish Society of Medical Oncology (SEOM), which have facilitated his significant contributions to the field.
Laurence Albigès
Laurence Albigès is a medical oncologist dedicated to genitourinary malignancies, and her main research focus is renal cell carcinoma (RCC). She has been part of the faculty at Gustave Roussy, France, since 2013. She is involved in the development of targeted agents and immune checkpoint blockers for metastatic RCC, and works in close collaboration with early drug department for Phase I trials relevant to RCC. Throughout her training and faculty positions, she has collaborated with major RCC clinical research centres in Europe and the USA, and built translational collaborations funded both from academic and industry support.
